The management of locally advanced breast cancer (LABC) is guided by scientific advances but is limited by local resources and expertise. LABC remains very common in low-resource countries. The Systemic Therapy Focus Group met as part of the Breast Health Global Initiative (BHGI) Summit in Budapest,
Medical and Radiation Oncology for Breast Cancer in Developing Countries with Particular Reference to Locally Advanced Breast Cancer
β Scribed by Elizabeth M. Murray
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 59 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Twentyβone cancers in 20 patients with locally advanced breast cancer were studied. Incisional biopsy was performed without using electrocautery. Tissue was obtained for histology and estrogen (ER) and progesterone (PR) receptors. Patients received chemotherapy after biopsy. All respond
## Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer The prognostic importance of angiogenesis in breast cancer has recently been discussed, and a significant relationship between vascular density and survival has been descri
## Abstract ## Purpose To evaluate dynamic contrastβenhanced magnetic resonance imaging (DCEβMRI) as a tool for early prediction of response to neoadjuvant chemotherapy (NAC) and 5βyear survival in patients with locally advanced breast cancer. ## Materials and Methods DCEβMRI was performed in pa